Hepatitis C treatment for people with severe mental illness.
about
Challenges in the treatment of HIV and HCV coinfection.Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia.Psychiatric clearance for patients started on interferon-alpha-based therapies.The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia.No increase in depression with low-dose maintenance peginterferon in prior non-responders with chronic hepatitis C.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidenceDepression following pegylated interferon-alpha: characteristics and vulnerability.Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness.Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.Birth cohort testing for hepatitis C virus: implications for clinical social workers in health care settings.Case report of 3 patients with severe mental illness and chronic hepatitis C virus infection treated with interferon-alpha.A comparison of risk factors for hepatitis C among young and older adult prisoners.
P2860
Q30389282-D508B436-AB25-4C84-859B-8FE5A855A727Q33566074-A2250BB7-C925-471E-8D4F-93F94F2A2144Q33708662-B5D8C617-AC35-4FBA-A948-338016092B7DQ34387635-7486A81B-D222-490C-AD32-5F8C2AC8A360Q34511200-07FAA8B5-0E29-4DC5-8E18-3F53559B8CD2Q34623350-457F18A3-21AE-4C25-A5B5-D655446674D9Q35540200-88600C7B-CC31-4E9F-B140-B0DEB4B13454Q36183715-8ABEF082-CC32-4ACE-8DE2-34D007C4DD5CQ36799786-E0ABE237-98EE-49D7-A33A-7A5AB87683B1Q37016316-495C1E3B-D9F1-4C9F-BE13-32491F170F6CQ37432112-E708D86C-4D01-4430-93C0-DD8ED9BE15F5Q37851006-29CEA1B7-7BD1-486F-BF2D-B13B04779988Q42210692-FE6DDF64-CEA0-4DF5-A5FD-A4430B18E1F1Q42270225-8EE53A5A-46CF-48FA-AE9A-5B37E3522914Q45405547-B9A65AAA-07D7-4F7A-B553-2EDF371FA4BDQ50640446-E8C3427C-76C4-4C66-910E-93A1CC083ADA
P2860
Hepatitis C treatment for people with severe mental illness.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Hepatitis C treatment for people with severe mental illness.
@ast
Hepatitis C treatment for people with severe mental illness.
@en
type
label
Hepatitis C treatment for people with severe mental illness.
@ast
Hepatitis C treatment for people with severe mental illness.
@en
prefLabel
Hepatitis C treatment for people with severe mental illness.
@ast
Hepatitis C treatment for people with severe mental illness.
@en
P2093
P356
P1433
P1476
Hepatitis C treatment for people with severe mental illness.
@en
P2093
Bryan J Marsh
Lisa A Mistler
Mary F Brunette
Ravi Luckoor
Robert M Vidaver
Stanley D Rosenberg
P304
P356
10.1176/APPI.PSY.47.2.93
P577
2006-03-01T00:00:00Z